Public Health Genomics. 2019 Oct 9:1-8. doi: 10.1159/000503129. [Epub ahead of print]
Do Women who Receive a Negative BRCA1/2 Risk Result Understand the Implications for Breast Cancer Risk?
Author information
- 1
- Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA, yue.guan@emory.edu.
- 2
- Department of Communication Studies, Franklin College of Arts and Sciences, University of Georgia, Athens, Georgia, USA.
- 3
- Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
- 4
- Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA.
Abstract
BACKGROUND/AIMS:
National guidelines endorse using evidence-based tools to identify those at risk for hereditary breast and ovarian cancer (HBOC). This study aimed to evaluate whether women deemed not to be at increased risk of being a BRCA mutation carrier; the majority of those screened, recall, understand and accept the implications of these results for breast cancer risk.
METHODS:
We conducted an online survey with women (n = 148) who screened negative on a brief HBOC screener.
RESULTS:
While women tended to accept HBOC screener as accurate (range 9-45; mean 32, SD 5.0), less than half (43%) accurately recalled their result. Only 52% understood that they were at low risk of carrying a mutation, and just 34% correctly understood their breast cancer risk. African American women were less likely to recall (33 vs. 53% respectively, OR 0.5, p = 0.03), understand (42 vs. 63% respectively, OR 0.4, p = 0.02), and accept (mean 31 vs. 33 respectively, β -2.1, p = 0.02) the result compared to Whites.
CONCLUSIONS:
Our findings show that those at low risk of carrying a BRCA1/2 mutation had limited understanding of the distinction between mutation risk and breast cancer risk. Theory-based communication strategies are needed to increase the understanding of the implications of being at low risk for hereditary cancers.
© 2019 S. Karger AG, Basel.
KEYWORDS:
Breast cancer; Genetic screening; Health communication; Health risk assessment; Hereditary breast and ovarian cancer syndrome
- PMID:
- 31597139
- DOI:
- 10.1159/000503129
No hay comentarios:
Publicar un comentario